Chronic Heart Failure
357
36
43
193
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
28 trials with published results (8%)
Research Maturity
193 completed trials (54% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.7%
24 terminated out of 357 trials
88.9%
+2.4% vs benchmark
17%
59 trials in Phase 3/4
15%
28 of 193 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 193 completed trials
Clinical Trials (357)
TELEREHAB-BR: Cardiovascular Rehabilitation Models Trial
The HEARTFELT Study
Effects of Resistance Training on Sarcopenia in Older Patients With Chronic Heart Failure
A Study to Evaluate the Safety, Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects
Vericiguat and Exercise Hemodynamics in Patients With HFrEF
Emulation of the EMPEROR-Reduced Trial Using Healthcare Claims Data
Emulation of the EMPEROR-Preserved Trial Using Healthcare Claims Data
A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure
A CSM-Based Volume Management Program for Chronic Heart Failure
Nurse-led Consultations in Heart Failure Within the 'FIL-EAS' Evaluation and Support Care Pathway for Heart Failure Patients
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions
The Effectiveness of Surgical Treatment of Patients With Ischemic Cardiomyopathy
SPECT-based Prediction and Evaluation of CRT Efficacy in CHF
The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)
Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure
Mobile-Based Telemedicine and Health-Related Quality of Life Among Patients With Chronic Heart Failure (MOBILE-HF)
Therapy Adjustment and IndividuaLized Response With Biomarker Observation in ReaL-world Heart Failure
Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise
Fecal Microbiota Transplantation for Elderly Patients With HFpEF: A Randomized Controlled Trial